Giant chorioangioma of placenta: a rare placental cause of polyhydramnios


  • Suneetha Allanki Department of Obstetrics and Gynecology, Government Medical College and Hospital, Nizamabad district, Telangana, India
  • Neethi Mala Mekala Department of Obstetrics and Gynecology, Government Medical College and Hospital, Nizamabad district, Telangana, India
  • Sunethri Padma Department of Pathology, Gandhi Medical College, Secunderabad, Telangana, India



Chorioangioma, Maternal and fetal complications, Placenta, Polyhydramnios, Ultrasonography, Vascular tumor


Chorioangioma belongs to benign nontrophoblastic primary vascular neoplasms of placenta, originating from primitive chorionic mesenchyme and has a cited prevalence of around 0.6% to 1% of all pregnancies. Though majority of them are asymptomatic, clinical course depends mainly on the size of the neoplasm. Giant chorioangiomas (> 4-5 centimetres in diameter) with an approximate prevalence of around one in 9000 to one in 50,000 pregnancies, have been associated with many adverse maternal and fetal complications. We report a case of 21-year-old primigravida lady, who presented to us at 37weeks 4 days period of gestation with backache and with clinically evident increased liquor. On evaluating the cause of her polyhydramnios, ultrasonography revealed a well-defined echogenic vascular mass measuring ~ 8х8 centimetres in the placenta, suggestive of chorioangioma. Though the condition is infrequent, through this case report, we emphasize that even placental factors need to be ruled out in evaluating causes of polyhydramnios. Despite large size of chorioangioma and associated hydramnios, our patient exceptionally didn’t have any fetal complications. With proper antenatal surveillance, optimal feto-maternal outcome can be expected as seen in our case.


Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler DM. Hydramnios: anomaly prevalence and sonographic detection. Obstet Gynecol. 2002;100(1):134.

Alexander E S, Spitz H B, Clark R A. Sonography of polyhydramnios. AJR Am J Roentgenol. 1982;138(2):343.

Golan A, Wolman I, Sagi J, Yovel I, David MP. Persistence of polyhydramnios during pregnancy – its significance and correlation with maternal and fetal complications. Gynecol Obstet Invest. 1994;37(1):18.

Haak MC, Oosterhof H, Mouw R. Pathophysiology and treatment of fetal anemia due to placental chorangioma. Ultrasound Obstet Gynecol. 1999;14(1):68-70.

Barros A, Freitas AC, Cabral AJ, Camacho MC ,Costa E, Leitao H et al. Giant placental chorioangioma: a rare cause of fetal hydrops. BMJ Case Reports. 2011;02:3880.

Dhar H. Giant placental chorioangioma with intrauterine fetal death. JNMA. 2013;52(190):384-87.

Clarke J. Account of a tumour found in the substance of the human placenta. Philos Trans R Soc. 1798;88:361.

Fox H, Sebire NJ. Non-trophoblastic tumors of the placenta. In Pathology of the Placenta (3rd edn), Fox H, Sebire N (eds). Saunders Elsevier: Philadelphia, 2007;401–430.

Kuhnel P. Placental chorioangioma Acta Obstetricia et Gynecologica Scandinavica, vol. 13, pp. 143-145, 1933.

Marchetti AA. A consideration of certain types of benign tumors of the placenta. Surg Gynecol Obstet. 1939;68:733-43.

Bracero LA, Davidian M, Cassidy S. Chorioangioma: diffuse angiomatous form. Chorioangioma. 1993;9:18-1.

Kirkpatrick AD, Podberesky DJ, Gray AE, McDermott JH. Best cases from the AFIP: Placental chorioangioma. Radiograph. 2007;27(4):1187-90.

Zalel Y, Gamzu R, Weiss Y, Schiff E, Shalmon B, Dolizky M. Role of Color Doppler Imaging in Diagnosing and managing pregnancies complicated by Placental chorioangioma. J Clin Ultrasound 2002; 30(5):264-9.

Wanapirak C, Tongsong T, Sirichotiyakul S, Chanprapaph P. Alcoholization: the choice of intrauterine treatment for chorioangioma. Journal of Obstet Gynaecol Res. 2002;28(2):71-5.






Case Reports